Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1816 AL 1830

En1 and Wnt signaling in midbrain dopaminergic neuronal development

Alves dos Santos MT, Smidt MP.

Neural Dev. 2011 May 10;6:23. doi: 10.1186/1749-8104-6-23.

Synuclein deposition and non-motor symptoms in Parkinson disease

Jellinger KA.

J Neurol Sci. 2011 Nov 15;310(1-2):107-11. doi: 10.1016/j.jns.2011.04.012. Epub 2011 May 12.

Sleep-wake disturbances in common neurodegenerative diseases: a closer look at selected aspects of the neural circuitry

Zhong G, Naismith SL, Rogers NL, Lewis SJ.

J Neurol Sci. 2011 Aug 15;307(1-2):9-14. doi: 10.1016/j.jns.2011.04.020. Epub 2011 May 13.

Combined measures of movement and force variability distinguish Parkinson's disease from essential tremor

Poon C, Robichaud JA, Corcos DM, Goldman JG, Vaillancourt DE.

Clin Neurophysiol. 2011 Nov;122(11):2268-75. doi: 10.1016/j.clinph.2011.04.014. Epub 2011 May 13.

Misfolded protein aggregates: mechanisms, structures and potential for disease transmission

Moreno-Gonzalez I, Soto C.

Semin Cell Dev Biol. 2011 Jul;22(5):482-7. doi: 10.1016/j.semcdb.2011.04.002. Epub 2011 May 5.

Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis

Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM.

Parkinsonism Relat Disord. 2011 Dec;17(10):724-9. doi: 10.1016/j.parkreldis.2011.04.016. Epub 2011 May 14.

Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins

Naeem A, Fazili NA.

Cell Biochem Biophys. 2011 Nov;61(2):237-50. doi: 10.1007/s12013-011-9200-x.

The influence of visual control on postural stability in Parkinson disease

Czechowicz B, Boczarska-Jedynak M, Opala G, Słomka K.

Neurol Neurochir Pol. 2011 Mar-Apr;45(2):132-9. doi: 10.1016/s0028-3843(14)60024-4.

Quality of life in young- compared with late-onset Parkinson's disease

Knipe MD, Wickremaratchi MM, Wyatt-Haines E, Morris HR, Ben-Shlomo Y.

Mov Disord. 2011 Sep;26(11):2011-8. doi: 10.1002/mds.23763. Epub 2011 May 13.

[Melatonin: its role in the system of neurohumoral regulation in man. Part 2]

Baksheev VI, Kolomoets NM.

Klin Med (Mosk). 2011;89(2):8-13.

Alzheimer's disease

Selkoe DJ.

Cold Spring Harb Perspect Biol. 2011 Jul 1;3(7):a004457. doi: 10.1101/cshperspect.a004457.

Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease

Rhee YH, Ko JY, Chang MY, Yi SH, Kim D, Kim CH, Shim JW, Jo AY, Kim BW, Lee H, Lee SH, Suh W, Park CH, Koh HC, Lee YS, Lanza R, Kim KS, Lee SH.

J Clin Invest. 2011 Jun;121(6):2326-35. doi: 10.1172/JCI45794. Epub 2011 May 16.

New insights into atypical parkinsonism

Wenning GK, Krismer F, Poewe W.

Curr Opin Neurol. 2011 Aug;24(4):331-8. doi: 10.1097/WCO.0b013e3283480569.

Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra

MacGillivray L, Reynolds KB, Sickand M, Rosebush PI, Mazurek MF.

Synapse. 2011 Nov;65(11):1166-72. doi: 10.1002/syn.20954. Epub 2011 Jun 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias